中国医药 (600056.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(中国医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 29,796,767,468.5021,624,971,226.5412,530,663,199.1837,592,649,532.9126,917,230,015.7017,651,453,835.068,519,901,885.91
 营业利润(元) 1,105,488,870.09873,142,857.99406,844,907.961,199,697,983.221,228,750,439.01960,879,538.36381,989,531.67
 利润总额(元) 1,109,150,508.67874,300,636.47406,610,349.261,196,127,041.171,235,256,040.00962,088,268.60388,562,652.68
 净利润(元) 783,662,782.78676,753,330.14320,582,342.33887,968,198.44938,055,896.51731,683,518.96300,838,706.54
 归属于母公司股东的净利润(元) 594,110,580.95543,547,678.43268,770,140.93735,705,209.39766,713,701.46616,019,753.64245,980,075.89
盈利能力:
 销售毛利率(%) 11.0811.129.8412.6312.7913.4813.10
 销售净利率(%) 2.633.132.562.363.494.153.53
 净资产收益率(%) 5.404.982.49----
 总资产报酬率ROA(%) 3.282.521.27----
 投入资本回报率ROIC(%) 3.423.091.534.454.723.811.52
营运能力:
 存货周转率(次) 4.112.971.67----
 应收账款周转率(次) 2.031.530.90----
 总资产周转率(次) 0.830.610.35----
偿债能力:
 资产负债率(%) 64.1565.4365.0563.3060.4859.1160.35
 股东权益比率(%) 29.3028.2328.7130.1332.3633.5432.51
 已获利息倍数(倍) 17.5037.6610.409.6511.1516.3212.10
 流动比率 1.531.531.551.501.691.751.70
 速动比率 1.111.111.081.081.211.251.21
发展能力:
 营业收入增长率(%) 10.7022.5147.083.750.71-3.36-0.61
 营业利润增长率(%) -10.03-9.136.5128.02-2.31-0.507.14
 税后利润增长率(%) -22.51-11.769.2713.70-8.25-6.8115.51
 净资产增长率(%) 3.324.315.535.443.673.962.80
 总资产增长率(%) 14.1023.9319.4915.393.39-2.29-1.81

前瞻产业研究院